Skip to main content
. 2017 May 1;33(5):410–423. doi: 10.1089/aid.2016.0204

FIG. 4.

FIG. 4.

IgG antibody binding to gp70 V1 V2 scaffold in RV144 and VAX trials. RV144 (red symbols), VAX003 (blue symbols), and VAX004 (green symbols); (A) and (B) symbols show GMTs of gp70 V1 V2 92TH023 and gp70 V1 V2 Case A2, respectively, with 95% confidence intervals and color coded numbers depict actual GMTs of RV144 (visits 1 and 8), VAX003 (visits A02, A05, and A09), and VAX004 (visits A02, A05, and A09); (C) and (D) show means and bars are standard deviations of RV144 (visits 1, 8, and 9), VAX003 (visits A02-A13), and VAX004 (visits A02-A13) at A405nm of gp70 V1 V2 92TH023 and gp70 V1 V2 Case A2, respectively. Solid symbols show 2 weeks post vaccination and hollow symbols show vaccination visits. VAX visit numbers are indicated below the x-axis with vaccination visits underlined. Responses above dotted line are considered positive. *p < .05; ***p < .001; ****p < .0001; ns, not significant.